MCM9
There are 2 papers on MCM9 in aging research: 2 observational studies in people.
2 papers study it1 finding
“Three of 155 (2%) participants carried possibly damaging heterozygous variants in MCM8, whereas 7 of 151 (5%) individuals carried possibly damaging heterozygous variants in MCM9.”
- 1 lab in 1 country
- Funders: Magee-Womens Research Institute and 1 more
- Humans2
Associations
1Primary ovarian insufficiency
upin humans1+5%
1 study
Primary ovarian insufficiency
upin humans1+5%
MCM9 is associated with primary ovarian insufficiency in humans (diagnosed prior to age 40 years) (5%).
“Three of 155 (2%) participants carried possibly damaging heterozygous variants in MCM8, whereas 7 of 151 (5%) individuals carried possibly damaging heterozygous variants in MCM9.”
Humansdiagnosed prior to age 40 yearsfemalesn = 151
MCM8 and MCM9 Nucleotide Variants in Women With Primary Ovarian Insufficiency
The Journal of clinical endocrinology and metabolism
Latest
Journal of Assisted Reproduction and Genetics
Genetic variants in diminished ovarian reserve and premature ovarian insufficiency: implications for assisted reproductive outcomes
Cohort study of 55 peopleReproductive system
The Journal of Clinical Endocrinology and Metabolism
MCM8 and MCM9 Nucleotide Variants in Women With Primary Ovarian Insufficiency
Cohort study of 155 peopleReproductive system